Tag: Pfizer Inc

The latest information on the upcoming round of Covid vaccines

As the world continues to grapple with the ongoing Covid-19 pandemic, new developments in the realm of vaccines have emerged. The Food and Drug Administration (FDA) recently advised vaccine manufacturers to develop monovalent Covid shots targeting a highly contagious strain of the virus called JN.1 for use in the U.S. starting this fall. This announcement […]

Long-term trial results show promise for Pfizer’s lung cancer drug

Pfizer has announced promising results from a late-stage trial of its drug Lorbrena for advanced lung cancer. The medicine has shown to help patients live longer without cancer progression for over five years, and also reduces the risk of brain progression. Lorbrena is specifically approved for patients with a mutation in the ALK gene, which […]

FDA greenlights new Moderna vaccine for elderly population against respiratory syncytial virus

The Food and Drug Administration recently approved Moderna’s RSV vaccine for adults aged 60 and above, marking the company’s second product to enter the U.S. market. This approval comes at a crucial time for Moderna as it seeks to diversify its revenue streams amidst declining demand for its Covid jab, its only commercially available product. […]

Understanding Human Cases and Vaccines

The recent detection of bird flu in dairy cows across nine U.S. states has raised concerns among health officials as they monitor and prepare to combat the virus in humans. Despite the low risk to the general public, the presence of the H5N1 strain in livestock and individuals highlights the need for vigilance and effective […]

Pfizer introduces latest cost-saving initiative

Pfizer Launches Multiyear Program to Reduce Costs and Rebound from Covid Business Decline Pfizer, the pharmaceutical giant, announced on Wednesday the launch of a new multiyear program aimed at reducing costs and recovering from the rapid decline of its Covid business. This initiative comes on the heels of a previous $4 billion cost-cutting effort that […]

Novavax and Sanofi team up to bring Covid vaccine to market, collaborate on combination shots

Novavax Signs Multibillion-Dollar Deal with Sanofi In a significant move for the pharmaceutical industry, Novavax announced on Friday a multibillion-dollar deal with French drugmaker Sanofi. The deal focuses on the co-commercialization of Novavax’s Covid vaccine starting next year, as well as the development of combination shots targeting both the coronavirus and the flu. Novavax’s stock […]

Back To Top